CHST6 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5109542-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA5109542 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
CHST6
Classification
Polyclonal
Conjugate
Unconjugated
Gene
CHST6
Gene Alias
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6; carbohydrate sulfotransferase 5; carbohydrate sulfotransferase 6; carbohydrate sulfotransferase 6; C-GlcNAc6ST; CHST6; corneal N-acetylglucosamine 6-sulfotransferase; corneal N-acetylglucosamine-6-O-sulfotransferase; Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta; glcNAc6ST-5; gn6st-5; GST4-beta; hCGn6ST; LOC489707; MCDC1; N-acetylglucosamine 6-O-sulfotransferase 5
Host Species
Rabbit
Purification Method
Affinity Chromatography
Regulatory Status
RUO
Gene ID (Entrez)
4166
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Western Blot
Concentration
1.59 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3
Gene Accession No.
Q9GZX3
Gene Symbols
CHST6
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 196-395 of human CHST6 (NP_067628.1).
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Immunogen sequence: RIVHLVRDPR AVLRSREQTA KALARDNGIV LGTNGTWVEA DPGLRVVREV CRSHVRIAEA ATLKPPPFLR GRYRLVRFED LAREPLAEIR ALYAFTGLSL TPQLEAWIHN ITHGSGPGAR REAFKTSSRN ALNVSQAWRH ALPFAKIRRV QELCAGALQL LGYRPVYSED EQRNLALDLV LPRGLNGFTW ASSTASHPRN Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues of keratan
- Mediates sulfation of keratan in cornea
- Keratan sulfate plays a central role in maintaining corneal transparency
- Acts on the non-reducing terminal GlcNAc of short and long carbohydrate substrates that have poly-N- acetyllactosamine structures.